SJS Investment Consulting’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $374 | Sell |
5
-3
| -38% | -$224 | ﹤0.01% | 1207 |
|
|
2025
Q1 | $509 | Buy |
8
+1
| +14% | +$64 | ﹤0.01% | 1245 |
|
|
2024
Q4 | $547 | Sell |
7
-3
| -30% | -$234 | ﹤0.01% | 1210 |
|
|
2024
Q3 | $805 | Sell |
10
-3
| -23% | -$242 | ﹤0.01% | 1141 |
|
|
2024
Q2 | $1.08K | Hold |
13
| – | – | ﹤0.01% | 1003 |
|
|
2024
Q1 | $1.11K | Hold |
13
| – | – | ﹤0.01% | 999 |
|
|
2023
Q4 | $1.11K | Sell |
13
-2
| -13% | -$171 | ﹤0.01% | 912 |
|
|
2023
Q3 | $1.35K | Buy |
15
+2
| +15% | +$179 | ﹤0.01% | 803 |
|
|
2023
Q2 | $1.11K | Buy |
13
+2
| +18% | +$170 | ﹤0.01% | 857 |
|
|
2023
Q1 | $911 | Sell |
11
-3
| -21% | -$248 | ﹤0.01% | 931 |
|
|
2022
Q4 | $1.1K | Buy |
14
+3
| +27% | +$236 | ﹤0.01% | 896 |
|
|
2022
Q3 | $1K | Buy |
+11
| New | +$1K | ﹤0.01% | 747 |
|
|
2022
Q1 | $0 | Buy |
+1
| New | – | ﹤0.01% | 960 |
|